These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8422277)

  • 1. Pancreatic cancer: how can we progress?
    Casper ES
    Eur J Cancer; 1993; 29A(2):171-2. PubMed ID: 8422277
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic adenocarcinoma responding to cisplatin based cytotoxic chemotherapy.
    Marshall E; Trotter JM; Metcalf C
    Aust N Z J Med; 1991 Oct; 21(5):780-1. PubMed ID: 1722092
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in chemotherapy for pancreatic adenocarcinoma].
    Hammel P
    Gastroenterol Clin Biol; 2002; 26(6-7):603-4. PubMed ID: 12193859
    [No Abstract]   [Full Text] [Related]  

  • 4. Epirubicin, etoposide and cisplatin in advanced pancreatic carcinoma.
    Di Bartolomeo M; Zampino MG; Di Leo A; Bajetta E
    Eur J Cancer; 1993; 29A(8):1215-6. PubMed ID: 8518036
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma.
    Raymond E; de Gramont A; Louvet C; Tournigand C; Demuynck B; Beerblock K; Carola E; Krulik M
    Eur J Cancer; 1997 Apr; 33(4):696-7. PubMed ID: 9274458
    [No Abstract]   [Full Text] [Related]  

  • 6. Advanced pancreatic cancer--5 years on.
    Rao S; Cunningham D
    Ann Oncol; 2002 Aug; 13(8):1165-8. PubMed ID: 12181237
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy in adenocarcinomas of the pancreas].
    Huguier M
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy.
    Kosakamoto H; Okada S; Ueno H; Okusaka T; Ikeda M; Tanaka N; Yoshimori M; Matsuno Y
    Hepatogastroenterology; 1999; 46(28):2621-4. PubMed ID: 10522052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
    Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
    Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine.
    Dougherty JB; Kelsen D; Kemeny N; Magill G; Botet J; Niedzwiecki D
    J Natl Cancer Inst; 1989 Nov; 81(22):1735-8. PubMed ID: 2681796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives in chemotherapy of pancreatic cancer.
    Klapdor R
    Eur J Surg Oncol; 1991 Apr; 17(2):153-66. PubMed ID: 1707835
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of combination chemotherapy of low-dose CDDP. Continuous infusion of 5-FU, and intermittent CPT-11 administration for 2 advanced pancreatic cancer cases with liver metastasis].
    Kobayashi A; Yamaguchi M
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1755-9. PubMed ID: 9757202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
    Kornek GV; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
    Br J Cancer; 2000 Jan; 82(1):98-103. PubMed ID: 10638974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
    Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erlotinib and pancreatic adenocarcinoma: uncertainty and hope.
    Zoras O; Batsis C
    Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S246-7. PubMed ID: 21630121
    [No Abstract]   [Full Text] [Related]  

  • 16. [Histologic assessment of treatment effect of preoperative chemoradiation in patients presenting with resectable pancreatic adenocarcinoma].
    Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Bibeau F; Scoazec JY
    Cancer Radiother; 2011 Apr; 15(2):97-105. PubMed ID: 21084206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin/methotrexate/fluorouracil in advanced pancreatic cancer.
    Porta C; Nastasi G; Spaghi A; Moroni M
    Lancet; 1990 Dec; 336(8728):1454-5. PubMed ID: 1978920
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets.
    Sclafani F; Iyer R; Cunningham D; Starling N
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):318-36. PubMed ID: 25921418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two cases of unresectable pancreatic cancer responding to combined chemotherapy with cisplatin, PSK and UFT].
    Sohma M; Kitagawa T; Okano S; Utsumi M; Mutoh E; Takeda S; Kanda M; Suzuki Y; Okamura K; Namiki M
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1926-9. PubMed ID: 3109332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leuprolide and tamoxifen in the treatment of pancreatic cancer. A phase II study.
    Zaniboni A; Meriggi F; Arcangeli G; Alghisi A; Huscher C; Marini G
    Eur J Cancer; 1994; 30A(1):128. PubMed ID: 8142155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.